![Daniel Petree](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Petree
Directeur/Membre du Conseil chez
SUTRO BIOPHARMA, INC.
Fortune : 65 651 $ au 31/05/2026
Profil
Daniel H.
Petree was the founder of P2 Partners LLC, founded in 2000, where the title held was Director from 2000 to 2012.
Mr. Petree was the founder of Four Oaks Partners LLC, founded in 2012, where the title held was Managing Director from 2012 to 2021.
Mr. Petree was the founder of Four Oaks Partners Consulting LLC, founded in 2012, where the title held was Member from 2012 to 2021.
Current jobs include Independent Director at Sutro Biopharma, Inc. since 2009 and Director & Head-Corporate Development at Lipidio Pharmaceuticals, Inc. Former jobs include Chairman at Lpath, Inc. from 2008 to 2016; Director at Cypress Bioscience, Inc. from 2004 to 2011; Director at Biocept, Inc. from 2009 to 2013; Director at Koronis Pharmaceuticals, Inc.; Director at NKT Therapeutics, Inc.; President & Chief Operating Officer at Axys Pharmaceuticals, Inc. from 1993 to 1999; Vice President-Health Care Group at Montgomery Securities, Inc.; Vice President-Business Development at TSI Corp from 1991 to 1993; Chief Financial Officer & Executive Vice President at Arris Pharmaceuticals Corp.; and Principal at Heller Ehrman White & McAuliffe LLP.
Education includes an undergraduate degree from Stanford University conferred in 1977 and a graduate degree from The University of Michigan Law School conferred in 1981.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC. 0,01 % | 05/06/2026 | 2 246 ( 0,01 % ) | 65 651 $ | 31/05/2026 |
Postes actifs de Daniel Petree
| Sociétés | Poste | Début |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Directeur/Membre du Conseil | 01/08/2009 |
Lipidio Pharmaceuticals, Inc.
 Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines | Directeur/Membre du Conseil | - |
Anciens postes connus de Daniel Petree
| Sociétés | Poste | Fin |
|---|---|---|
Four Oaks Partners Consulting LLC | Fondateur | 01/01/2021 |
Four Oaks Partners LLC | Directeur Général | 01/01/2021 |
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Discovers and develops lipidomic-based therapeutic antibodies | Président | 01/01/2016 |
| BIOCEPT, INC. | Directeur/Membre du Conseil | 01/01/2013 |
P2 Partners LLC
 P2 Partners LLC Financial ConglomeratesFinance Provides real estate investment services | Fondateur | 01/01/2012 |
Formation de Daniel Petree
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Health Technology |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers integrated drugs | Health Technology |
Biocept, Inc.
 Biocept, Inc. Medical/Nursing ServicesHealth Services Develops and performs clinical laboratory tests to detection & analysis of tumor cells and cell-free DNA from cerebrospinal fluid | Health Services |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Montgomery Securities, Inc.
 Montgomery Securities, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
TSI Corp
 TSI Corp Miscellaneous Commercial ServicesCommercial Services Provides lab testing services | Commercial Services |
Arris Pharmaceuticals Corp. | |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Discovers and develops lipidomic-based therapeutic antibodies | Health Technology |
P2 Partners LLC
P2 Partners LLC Financial ConglomeratesFinance Provides real estate investment services | Finance |
Koronis Pharmaceuticals, Inc.
 Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics based on viral decay acceleration | Health Technology |
Heller Ehrman White & McAuliffe LLP
 Heller Ehrman White & McAuliffe LLP Miscellaneous Commercial ServicesCommercial Services Heller Ehrman White & McAuliffe LLP is a private company based in San Francisco, CA. | Commercial Services |
NKT Therapeutics, Inc.
 NKT Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnology products and services | Health Technology |
Four Oaks Partners LLC | |
Four Oaks Partners Consulting LLC | |
The University of Michigan Law School
 The University of Michigan Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipidio Pharmaceuticals, Inc.
Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines | Health Technology |
